This is for filing the scrutinizer''s report along with the voting results for the Postal Ballot conducted pursuant to the notice dated May 16, 2025.
NOVARTIND · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Novartis India announced the results of a postal ballot concluded on June 15, 2025, with both resolutions passed by members. The first was a special resolution to re-appoint Mr. Sanker Parameswaran (DIN: 00008187) as an Independent Director for a second term of 5 years, from June 22, 2025 to June 21, 2030, which received overwhelming support with 99.99% of votes in favor (17,540,567 votes out of 17,541,870 polled). The second was an ordinary resolution to approve a Related Party Transaction between Novartis Pharma AG (parent) and Novartis India Limited, which was also approved with 98.72% of votes in favor (90,026 votes in favor out of 91,190 polled), with promoter group members abstaining as they were considered interested parties. A total of 35,438 shareholders were on the record date, and voting was conducted entirely through remote e-voting via NSDL.
The re-appointment of an existing Independent Director ensures continuity on the board, while the approved RPT paves the way for the company to formally enter into transactions with its Swiss parent Novartis Pharma AG, which is important for its ongoing operations. Both resolutions received near-unanimous support, indicating strong shareholder alignment with management's proposals.